BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Firdous J, Islam MA, Park SM, Cheon IS, Shim BS, Yoon HS, Song M, Chang J, Choi YJ, Park YM, Boraschi D, Han SH, Cho CS, Yun CH. Induction of long-term immunity against respiratory syncytial virus glycoprotein by an osmotic polymeric nanocarrier. Acta Biomater 2014;10:4606-17. [PMID: 25110285 DOI: 10.1016/j.actbio.2014.07.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Boraschi D, Fadeel B, Duschl A. Immune System. Adverse Effects of Engineered Nanomaterials. Elsevier; 2017. pp. 313-37. [DOI: 10.1016/b978-0-12-809199-9.00013-6] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Kye YC, Park SM, Shim BS, Firdous J, Kim G, Kim HW, Ju YJ, Kim CG, Cho CS, Kim DW, Cho JH, Song MK, Han SH, Yun CH. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection. Acta Biomater 2019;90:362-72. [PMID: 30922953 DOI: 10.1016/j.actbio.2019.03.049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
3 Thakur A, Foged C. Nanoparticles for mucosal vaccine delivery. Nanoengineered Biomaterials for Advanced Drug Delivery. Elsevier; 2020. pp. 603-46. [DOI: 10.1016/b978-0-08-102985-5.00025-5] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
4 Kim CG, Kye YC, Yun CH. The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses. Pharmaceutics 2019;11:E612. [PMID: 31731667 DOI: 10.3390/pharmaceutics11110612] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
5 Swartzwelter BJ, Fux AC, Johnson L, Swart E, Hofer S, Hofstätter N, Geppert M, Italiani P, Boraschi D, Duschl A, Himly M. The Impact of Nanoparticles on Innate Immune Activation by Live Bacteria. Int J Mol Sci 2020;21:E9695. [PMID: 33353206 DOI: 10.3390/ijms21249695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jorquera PA, Tripp RA. Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus. Vaccines (Basel) 2016;4:E45. [PMID: 27918420 DOI: 10.3390/vaccines4040045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
7 Rajendrakumar SK, Mohapatra A, Singh B, Revuri V, Lee YK, Kim CS, Cho CS, Park IK. Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor. Polymers (Basel) 2018;10:E1063. [PMID: 30960988 DOI: 10.3390/polym10101063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Islam MA, Firdous J, Badruddoza AZM, Reesor E, Azad M, Hasan A, Lim M, Cao W, Guillemette S, Cho CS. M cell targeting engineered biomaterials for effective vaccination. Biomaterials 2019;192:75-94. [PMID: 30439573 DOI: 10.1016/j.biomaterials.2018.10.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
9 Ariful Islam M, Park T, Firdous J, Li H, Jimenez Z, Lim M, Choi J, Yun C, Cho C. Essential cues of engineered polymeric materials regulating gene transfer pathways. Progress in Materials Science 2022. [DOI: 10.1016/j.pmatsci.2022.100961] [Reference Citation Analysis]
10 Shen C, Li J, Zhang Y, Li Y, Shen G, Zhu J, Tao J. Polyethylenimine-based micro/nanoparticles as vaccine adjuvants. Int J Nanomedicine 2017;12:5443-60. [PMID: 28814862 DOI: 10.2147/IJN.S137980] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 6.4] [Reference Citation Analysis]
11 Boraschi D, Italiani P. From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology. Vaccines (Basel) 2015;3:930-9. [PMID: 26556378 DOI: 10.3390/vaccines3040930] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
12 Masjedi M, Montahaei T, Sharafi Z, Jalali A. Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103184] [Reference Citation Analysis]